From: Ian Horrocks ([email protected])
Date: 06/08/01
Dear All I thought you would be interested to know that as part of their corporate knowledge management strategy GlaxoSmithKline Pharmaceuticals have commissioned a new gene ontology the specification for which explicitly states that it must be delivered in DAML+OIL. This is just the latest indicator of the major impact that DAML+OIL is having in the bio-informatics arena. Regards, Ian
This archive was generated by hypermail 2.1.4 : 04/02/02 EST